(Q54628920)
Statements
Recombinant human erythropoietin treatment may improve quality of life and cognitive function in chronic hemodialysis patients. (English)
Wolcott DL
Marsh JT
La Rue A
Carr C
Nissenson AR
1 December 1989
14
6
478-485